6.BETA.-CHLORO-7A-HYDROXY-6,7-DIHYDROCYPROTERONE ACETATE
UNII 62GJ5G3LDT

Substance Identification & Data

This profile provides standardized clinical and technical data for 6.beta.-chloro-7a-hydroxy-6,7-dihydrocyproterone Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 62GJ5G3LDT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23814-84-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

62GJ5G3LDT

CAS Registry Number

23814-84-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

6.BETA.-CHLORO-7A-HYDROXY-6,7-DIHYDROCYPROTERONE ACETATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H31ClO5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MQCUOQYFPPINFT-SXXHTHPYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

13423627

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@]12([C@]3([H])[C@@H]([C@H](C4=CC(=O)[C@]5([C@]([C@@]4([C@]3(CC[C@@]1([C@@](C(C)=O)(CC2)OC(C)=O)C)[H])C)([H])C5)[H])Cl)O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 6.beta.-chloro-7a-hydroxy-6,7-dihydrocyproterone Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

6.BETA.-CHLORO-7A-HYDROXY-6,7-DIHYDROCYPROTERONE ACETATE

CYPROTERONE ACETATE IMPURITY G [EP IMPURITY]

Systematic Nomenclature

(1S,2S,3S,5R,9S,10S,11R,12S,15R,16S)-15-ACETYL-9-CHLORO-10-HYDROXY-2,16-DIMETHYL-6-OXOPENTACYCLO(9.7.0.0^(2,8).0^(3,5).0^(12,16))OCTADEC-7-EN-15-YL ACETATE

SYS

(2AR,3AS,3BS,3CS,5AS,6R,8AS,8BR,9S,10S)-6-ACETYL-10-CHLORO-9-HYDROXY-3B,5A-DIMETHYL-2-OXO-2,2A,3,3A,3B,3C,4,5,5A,6,7,8,8A,8B,9,10-HEXADECAHYDROCYCLOPENTA(A)CYCLOPROPA(G)PHENANTHREN-6-YL ACETATE

SYS

3'H-CYCLOPROPA(1,2)PREGNA-1,4-DIENE-3,20-DIONE, 17-(ACETYLOXY)-6-CHLORO-1,2-DIHYDRO-7-HYDROXY-, (1.BETA.,2.BETA.,6.BETA.,7.ALPHA.)-

SYS

3'H-CYCLOPROPA(1,2)PREGNA-1,4-DIENE-3,20-DIONE, 6.BETA.-CHLORO-1.BETA.,2.BETA.-DIHYDRO-7.ALPHA.,17-DIHYDROXY-, 17-ACETATE

SYS

6.BETA.-CHLORO-7.ALPHA.-HYDROXY-3,20-DIOXO-1.BETA.,2.BETA.-DIHYDRO-3'H-CYCLOPROPA(1,2)PREGNA-1,4-DIEN-17-YL ACETATE

SYS

CYCLOPROPA(1,2)CYCLOPENTA(A)PHENANTHRENE, 3'H-CYCLOPROPA(1,2)PREGNA-1,4-DIENE-3,20-DIONE DERIV.

SYS

External Clinical & Regulatory Resources

Previous UNII62GJ4SI7G8

Next UNII62GM7VW6AO